Bellerophon Therapeutics, Inc.·4

Mar 20, 4:23 PM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed Mar 20, 2017

Insider Transaction Report

Form 4
Period: 2017-03-16
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Award

    Common Stock

    2017-03-16+120,193263,050 total

Documents

1 file
  • 4
    wf-form4_149004136704572.xmlPrimary

    FORM 4